Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Angelos Halaris

Showing results (11-20 of 59) with videos related to

Pageof 6
Sort By:
Journal of Personalized Medicine|September 28, 2023
Associations of BDNF/BDNF-AS SNPs with Depression, Schizophrenia, and Bipolar DisorderAnton Shkundin, Angelos Halaris
Modern Trends in Pharmacopsychiatry|July 25, 2017
Pharmacological and Nonpharmacological Interventions to Arrest Neuroprogression in Psychiatric DisordersFotini Boufidou, Angelos Halaris
Advances in Experimental Medicine and Biology|March 23, 2023
The Glutamatergic System in Treatment-Resistant Depression and Comparative Effectiveness of Ketamine and Esketamine: Role of Inflammation?Angelos Halaris, John Cook
Progress in Neuro-Psychopharmacology & Biological Psychiatry|July 16, 2022
Adjunctive dopaminergic enhancement of esketamine in treatment-resistant depressionJohn Cook, Angelos Halaris
Human Psychopharmacology|October 31, 2002
Imidazoline receptors: possible involvement in the pathophysiology and treatment of depressionAngelos Halaris, John E Piletz
Frontiers in Psychiatry|July 15, 2022
Imbalances in Kynurenines as Potential Biomarkers in the Diagnosis and Treatment of Psychiatric DisordersAye-Mu Myint, Angelos Halaris
Journal of Psychiatric Research|May 21, 2013
VEGF and depression: a comprehensive assessment of clinical dataAnne Clark-Raymond, Angelos Halaris
Modern Trends in Pharmacopsychiatry|October 8, 2014
PrefaceAngelos Halaris, Brian E Leonard
Current Diabetes Reports|November 9, 2014
Shared neurobiological pathways between type 2 diabetes and depressive symptoms: a review of morphological and neurocognitive findingsTodd Doyle, Angelos Halaris, Murali Rao
Journal of Personalized Medicine|February 26, 2026
Contextual Regulation of the Kynurenine Pathway and Its Relevance for Personalized PsychiatryStephen Murata, Gregory Oxenkrug, Angelos Halaris
Pageof 6

Showing results (11-20 of 59) with videos related to

Sort By:
Pageof 6
Journal of Personalized Medicine|September 28, 2023
Associations of BDNF/BDNF-AS SNPs with Depression, Schizophrenia, and Bipolar DisorderAnton Shkundin, Angelos Halaris
Modern Trends in Pharmacopsychiatry|July 25, 2017
Pharmacological and Nonpharmacological Interventions to Arrest Neuroprogression in Psychiatric DisordersFotini Boufidou, Angelos Halaris
Advances in Experimental Medicine and Biology|March 23, 2023
The Glutamatergic System in Treatment-Resistant Depression and Comparative Effectiveness of Ketamine and Esketamine: Role of Inflammation?Angelos Halaris, John Cook
Progress in Neuro-Psychopharmacology & Biological Psychiatry|July 16, 2022
Adjunctive dopaminergic enhancement of esketamine in treatment-resistant depressionJohn Cook, Angelos Halaris
Human Psychopharmacology|October 31, 2002
Imidazoline receptors: possible involvement in the pathophysiology and treatment of depressionAngelos Halaris, John E Piletz
Frontiers in Psychiatry|July 15, 2022
Imbalances in Kynurenines as Potential Biomarkers in the Diagnosis and Treatment of Psychiatric DisordersAye-Mu Myint, Angelos Halaris
Journal of Psychiatric Research|May 21, 2013
VEGF and depression: a comprehensive assessment of clinical dataAnne Clark-Raymond, Angelos Halaris
Modern Trends in Pharmacopsychiatry|October 8, 2014
PrefaceAngelos Halaris, Brian E Leonard
Current Diabetes Reports|November 9, 2014
Shared neurobiological pathways between type 2 diabetes and depressive symptoms: a review of morphological and neurocognitive findingsTodd Doyle, Angelos Halaris, Murali Rao
Journal of Personalized Medicine|February 26, 2026
Contextual Regulation of the Kynurenine Pathway and Its Relevance for Personalized PsychiatryStephen Murata, Gregory Oxenkrug, Angelos Halaris
Pageof 6